NXS 4.44% 23.5¢ next science limited

Ann: Next Science Investor Presentation May 2019, page-39

  1. 24 Posts.
    lightbulb Created with Sketch. 10
    To be clear, the FDA 510k clearances indicate two things:
    1. That the products are safe
    2. That they're similar enough to other products that supporting research or evidence doesn't need to be provided for assessment.

    The approval process doesn't assess or validate the efficacy of the product or the quality of supporting evidence.

    To make claims that a technology is substantially different in action or effectiveness would require a 'de novo' approval which is much harder and does require serious scrutiny of evidence and claims.
 
watchlist Created with Sketch. Add NXS (ASX) to my watchlist
(20min delay)
Last
23.5¢
Change
0.010(4.44%)
Mkt cap ! $68.54M
Open High Low Value Volume
22.0¢ 23.5¢ 21.5¢ $46.14K 206.3K

Buyers (Bids)

No. Vol. Price($)
4 130676 21.5¢
 

Sellers (Offers)

Price($) Vol. No.
23.5¢ 19533 2
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
NXS (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.